CLINICAL_TRIALS
trial_result
· 2021-04-28
Clinical Trial Update: Safety and Efficacy of ORM-12741 in Patients With Alzheimer's Disease [Phase 2]
Summary
Phase 2 clinical trial update on ORM-12741 for Alzheimer's disease reporting safety and efficacy results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Orion Corporation, Orion Pharma | Conditions: Alzheimer's Disease | Phase 2 | Status: COMPLETED | Results posted: 2021-04-28